Hakariya H, Ohnishi M, Tanimoto T. Japan initiates market authorization of weight-loss drug semaglutide under universal health coverage, but with stringent prescription restrictions. Diabetes Obes Metab 2024;26:3006-3008.
PMID: 38747140